Second Sight Medical Products, Inc. Announces Record Date, Subscription Pricing, Expiration Date for Rights Offering and Effectiveness of Its Registration Statement

by Business Wire • 2017/02/06 • 0 Comments

SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (Nasdaq:EYES), ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced that it has set 5:00 p.m. Eastern Time on February 10, 2017 as the record date for its upcoming rights offering. Second Sight intends to issue non-transferable subscription rights to purchase units, composed of a share of Second Sight common

← BioTime Expands Ophthalmology Portfolio With Global In-Licensing Agreement for Next-Generation Retinal Disease Therapy From University of Pittsburgh Medical Center

PUBLICATION EXCLUSIVE: Multifocal IOLs: Patient selection and optical performance →

Post navigation